HDAC6‑selective inhibitor synergistically enhances the anticancer activity of immunomodulatory drugs in multiple myeloma
Hye‐Rim Won(Yonsei University), So Hee Kwon(Yonsei University)
Cited by 17
Related Papers
Histone demethylase KDM4C controls tumorigenesis of glioblastoma by epigenetically regulating p53 and c-Myc
|Cell Death and Disease|2021|55
The HDAC6 inhibitor ACY‑1215 enhances the anticancer activity of oxaliplatin in colorectal cancer cells
|International Journal of Oncology|2018|38
HPV-mediated nuclear export of HP1γ drives cervical tumorigenesis by downregulation of p53
|Cell Death and Differentiation|2020|28
HDAC8 Deacetylates HIF-1α and Enhances Its Protein Stability to Promote Tumor Growth and Migration in Melanoma
|Cancers|2023|26
Ubiquitin-mediated stabilization of KDM5B drives chemoresistance via repression of dual-specificity phosphatase 4 in ovarian cancer
|Signal Transduction and Targeted Therapy|2026|1